Healthcare provider profile · identity verified

Bassel Abou Saab, M.D.

Family Practice · KENHORST, PA · NPI 1396973673

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	504	139
Gabapentin	Gabapentin	330	63
Amlodipine Besylate	Amlodipine Besylate	289	80
Omeprazole	Omeprazole	251	58
Lisinopril	Lisinopril	225	68
Metformin Hcl	Metformin Hcl	201	57
Pantoprazole Sodium	Pantoprazole Sodium	196	42
Metoprolol Succinate	Metoprolol Succinate	191	59
Losartan Potassium	Losartan Potassium	190	51
Levothyroxine Sodium	Levothyroxine Sodium	174	41
Tramadol Hcl	Tramadol Hcl	167	33
Albuterol Sulfate Hfa	Albuterol Sulfate	156	42
Fluticasone Propionate	Fluticasone Propionate	112	29
Sertraline Hcl	Sertraline Hcl	111	30
Metoprolol Tartrate	Metoprolol Tartrate	108	29
Mirtazapine	Mirtazapine	105	27
Simvastatin	Simvastatin	101	32
Jardiance	Empagliflozin	98	18
Hydrochlorothiazide	Hydrochlorothiazide	90	26
Tamsulosin Hcl	Tamsulosin Hcl	85	22
Duloxetine Hcl	Duloxetine Hcl	77	21
Ozempic	Semaglutide	77	16
Trulicity	Dulaglutide	73	12
Tradjenta	Linagliptin	71	14
Clopidogrel	Clopidogrel Bisulfate	70	19
Rosuvastatin Calcium	Rosuvastatin Calcium	68	18
Eliquis	Apixaban	65	20
Buspirone Hcl	Buspirone Hcl	63	15
Clonazepam	Clonazepam	62	15
Allopurinol	Allopurinol	61	17
Furosemide	Furosemide	61	19
Trazodone Hcl	Trazodone Hcl	58	14
Escitalopram Oxalate	Escitalopram Oxalate	57	18
Januvia	Sitagliptin Phosphate	57	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	57	11
Alprazolam	Alprazolam	53	13
Famotidine	Famotidine	53	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	52	15
Meloxicam	Meloxicam	49	13
Bupropion Xl	Bupropion Hcl	48	suppressed
Topiramate	Topiramate	47	suppressed
Potassium Chloride	Potassium Chloride	46	suppressed
Pregabalin	Pregabalin	43	suppressed
Diclofenac Sodium	Diclofenac Sodium	41	16
Dicyclomine Hcl	Dicyclomine Hcl	40	suppressed
Montelukast Sodium	Montelukast Sodium	40	suppressed
Pravastatin Sodium	Pravastatin Sodium	40	suppressed
Valacyclovir	Valacyclovir Hcl	40	13
Citalopram Hbr	Citalopram Hydrobromide	38	11
Myrbetriq	Mirabegron	36	suppressed
Ezetimibe	Ezetimibe	34	suppressed
Lorazepam	Lorazepam	34	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	34	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	33	31
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Meclizine Hcl	Meclizine Hcl	31	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	suppressed
Nateglinide	Nateglinide	30	suppressed
Prednisone	Prednisone	30	23
Bupropion Hcl Sr	Bupropion Hcl	29	suppressed
Celecoxib	Celecoxib	29	suppressed
Linzess	Linaclotide	29	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	12
Metformin Hcl Er	Metformin Hcl	28	suppressed
Methylprednisolone	Methylprednisolone	28	24
Oxycodone Hcl	Oxycodone Hcl	28	suppressed
Carvedilol	Carvedilol	27	suppressed
Valsartan	Valsartan	27	13
Xarelto	Rivaroxaban	26	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	26	suppressed
Diazepam	Diazepam	25	suppressed
Glipizide Er	Glipizide	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	21
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Spironolactone	Spironolactone	21	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	20	suppressed
Atenolol	Atenolol	20	suppressed
Lidocaine	Lidocaine	20	suppressed
Methocarbamol	Methocarbamol	20	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	14
Chlorhexidine Gluconate	Chlorhexidine Gluconate	19	suppressed
Enalapril Maleate	Enalapril Maleate	19	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Novolog Flexpen	Insulin Aspart	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	18	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Alendronate Sodium	Alendronate Sodium	17	suppressed
Cephalexin	Cephalexin	17	17
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	16
Janumet	Sitagliptin Phos/Metformin Hcl	17	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Labetalol Hcl	Labetalol Hcl	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Synthroid	Levothyroxine Sodium	15	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Glimepiride	Glimepiride	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	12	suppressed
Lactulose	Lactulose	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Cefadroxil	Cefadroxil	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error